Breast Cancer: Targets and Therapy (Mar 2018)

Profile of buparlisib and its potential in the treatment of breast cancer: evidence to date [Corrigendum]

  • Criscitiello C,
  • Viale G,
  • Curigliano G,
  • Goldhirsch A

Journal volume & issue
Vol. Volume 10
pp. 51 – 52

Abstract

Read online

Criscitiello C, Viale G, Curigliano G, et al. Profile ofbuparlisib and its potential in the treatment of breast cancer:evidence to date. Breast Cancer (Dove Med Press).2018;10:23–29.On page 23, Giuseppe Curigliano’s affiliation was incorrcectlylisted as European Institute of Oncology, Milan, Italy.It should be Department of Oncology and Hemato-Oncology,Division of Early Drug Development for Innovative Therapy,University of Milan, European Institute of Oncology, Milan,Italy.Read the original article